Oxford Nanopore

Details

  • Number of employees
    200-500
  • Company Type
    Large Multi-national

Oxford Nanopore Technologies is a pioneering company based in the UK, renowned for its innovative approach to DNA and RNA sequencing. Established with the vision of making genomic information accessible to everyone, the company has developed cutting-edge technologies that enable real-time analysis of biological data.

At the core of Oxford Nanopore’s offerings is its unique nanopore sequencing technology, which allows for the direct reading of nucleic acids. This technology is not only scalable but also versatile, catering to a wide range of applications from academic research to clinical diagnostics.

The company’s flagship product, the MinION, is a portable sequencer that has revolutionised the field by providing researchers with the ability to conduct sequencing in diverse environments, including remote locations. Additionally, the PromethION platform offers high-throughput sequencing capabilities, making it suitable for large-scale projects.

Oxford Nanopore is committed to advancing scientific discovery and improving healthcare outcomes through its products. The company collaborates with various institutions and organisations globally, fostering partnerships that enhance research and innovation.

With a strong emphasis on user-friendly interfaces and software, Oxford Nanopore ensures that its technology is accessible to both seasoned scientists and newcomers to the field. The company also prioritises education and training, providing resources to help users maximise the potential of their sequencing platforms.

As a leader in the genomics industry, Oxford Nanopore continues to push the boundaries of what is possible in DNA sequencing, aiming to empower researchers and clinicians alike. The company envisions a future where genomic data is seamlessly integrated into everyday healthcare, driving personalised medicine and improved patient outcomes.

In summary, Oxford Nanopore Technologies stands at the forefront of genomic innovation, dedicated to transforming the way we understand and utilise genetic information.

>